BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sabbagh DK, Barmayehvar B, Nguyen T, Edgar RG, Turner AM. Managing panniculitis in alpha-1 antitrypsin deficiency: Systematic review of evidence behind treatment. World J Dermatol 2018; 7(1): 1-8 [DOI: 10.5314/wjd.v7.i1.1]
URL: https://www.wjgnet.com/2218-6190/full/v7/i1/1.htm
Number Citing Articles
1
Anita Pye, Alice M Turner. Experimental and investigational drugs for the treatment of alpha-1 antitrypsin deficiencyExpert Opinion on Investigational Drugs 2019; 28(10): 891 doi: 10.1080/13543784.2019.1672656
2
Priya S Chukowry, Ross Gareth Edgar, Alice M Turner. Alpha 1 antitrypsin deficiency: a rare multisystem disease, predominantly affecting the lungExpert Opinion on Orphan Drugs 2019; 7(7-8): 315 doi: 10.1080/21678707.2019.1651640
3
Sabina Janciauskiene, Tobias Welte. α1-Antitrypsin Deficiency2019; : 159 doi: 10.1183/2312508X.10033418
4
Judith A. Newell, Christine Donahue, D. Kyle Hogarth. An NP's guide to diagnosing and treating alpha-1 antitrypsin deficiencyThe Nurse Practitioner 2019; 44(4): 13 doi: 10.1097/01.NPR.0000554086.13073.ec
5
Franck Rahaghi, Laurel Omert, Virginia Clark, Robert A. Sandhaus. Managing the Alpha-1 patient in the ICU: Adapting broad critical care strategies in AATDJournal of Critical Care 2019; 54: 212 doi: 10.1016/j.jcrc.2019.08.027
6
Alessandro N. Franciosi, James Ralph, Naoimh J. O'Farrell, Colm Buckley, Christian Gulmann, Marina O'Kane, Tomás P. Carroll, Noel G. McElvaney. Alpha-1 antitrypsin deficiency–associated panniculitisJournal of the American Academy of Dermatology 2021;  doi: 10.1016/j.jaad.2021.01.074
7
Vickram Tejwani, James K. Stoller. The spectrum of clinical sequelae associated with alpha-1 antitrypsin deficiencyTherapeutic Advances in Chronic Disease 2021; : 204062232199569 doi: 10.1177/2040622321995691